HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical Impact of Inherited and Acquired Genetic Variants in Mastocytosis.

Abstract
Mastocytosis is a rare and complex disease characterized by expansion of clonal mast cells (MC) in skin and/or various internal organ systems. Involvement of internal organs leads to the diagnosis of systemic mastocytosis (SM). The WHO classification divides SM into indolent SM, smoldering SM and advanced SM variants, including SM with an associated hematologic neoplasm, aggressive SM, and MC leukemia. Historically, genetic analysis of individuals with pure cutaneous mastocytosis (CM) and SM have focused primarily on cohort studies of inherited single nucleotide variants and acquired pathogenic variants. The most prevalent pathogenic variant (mutation) in patients with SM is KIT p.D816V, which is detectable in most adult patients. Other somatic mutations have also been identified-especially in advanced SM-in TET2, SRSF2, ASXL1, RUNX1, CBL and JAK2, and shown to impact clinical and cellular phenotypes. Although only small patient cohorts have been analyzed, disease associations have also been identified in several germline variants within genes encoding certain cytokines or their receptors (IL13, IL6, IL6R, IL31, IL4R) and toll-like receptors. More recently, an increased prevalence of hereditary alpha-tryptasemia (HαT) caused by increased TPSAB1 copy number encoding alpha-tryptase has been described in patients with SM. Whereas HαT is found in 3-6% of general Western populations, it is identified in up to 17% of patients with SM. In the current manuscript we review the prevalence, functional role and clinical impact of various germline and somatic genetic variants in patients with mastocytosis.
AuthorsBoguslaw Nedoszytko, Michel Arock, Jonathan J Lyons, Guillaume Bachelot, Lawrence B Schwartz, Andreas Reiter, Mohamad Jawhar, Juliana Schwaab, Magdalena Lange, Georg Greiner, Gregor Hoermann, Marek Niedoszytko, Dean D Metcalfe, Peter Valent
JournalInternational journal of molecular sciences (Int J Mol Sci) Vol. 22 Issue 1 (Jan 02 2021) ISSN: 1422-0067 [Electronic] Switzerland
PMID33401724 (Publication Type: Journal Article, Review)
Chemical References
  • ADGRE2 protein, human
  • Cytokines
  • IL31 protein, human
  • IL6 protein, human
  • Interleukin-13
  • Interleukin-6
  • Interleukins
  • MRGPRX2 protein, human
  • Nerve Tissue Proteins
  • Receptors, G-Protein-Coupled
  • Receptors, Neuropeptide
  • TLR2 protein, human
  • Toll-Like Receptor 2
  • KIT protein, human
  • Proto-Oncogene Proteins c-kit
  • PLCG2 protein, human
  • Phospholipase C gamma
Topics
  • Cytokines (genetics)
  • Humans
  • Interleukin-13 (genetics)
  • Interleukin-6 (genetics)
  • Interleukins (genetics)
  • Mast Cells (pathology)
  • Mastocytosis, Systemic (diagnosis, genetics, metabolism, physiopathology)
  • Nerve Tissue Proteins (genetics)
  • Phospholipase C gamma (genetics)
  • Polymorphism, Genetic
  • Proto-Oncogene Proteins c-kit (genetics, metabolism)
  • Receptors, G-Protein-Coupled (genetics)
  • Receptors, Neuropeptide (genetics)
  • Toll-Like Receptor 2 (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: